Printer Friendly

Hi-tech eye treatment success.

THE Gulf Diabetes Specialist Centre is now using new technology to treat conical cornea lesions, a common disease in Bahrain and the Gulf.

Dr Wael Wajeeh, ophthalmology surgeon at the centre and a FRCS, said the new treatment was first successfully used in a Swiss medical centre in 2001. It was then accredited by the European Union in 2009 and will be accredited by the US Food and Drug Administration this year, after positive clinical results were achieved in 11 specialist centres in the US.

Riboflavin, vitamin B2, is used in the form of eye drops, then 30 minutes later the eye is exposed to ultra-violet rays for another 30 minutes.

This strengthens the texture of the cornea and assists in retaining its natural form.

Dr Wajeeh added the new technology will limit the need for cornea implantation and is much safer to use.

Copyright 2012 Al Hilal Publishing & Marketing Group

Provided by an company
COPYRIGHT 2012 Al Bawaba (Middle East) Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Gulf Daily News (Manama, Bahrain)
Date:Mar 2, 2012
Previous Article:Civil defence successes praised.
Next Article:Losing credibility.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters